Bond.az White LogoBond.az Black Logo

Blue Bird director Daniel Thau buys $19,527 of BLBD stock

Blue Bird Corp director Daniel Thau buys $19,527 of BLBD stock. Stock up 58% over past year. Read more on Bond.az.

David Wilson
ByDavid Wilson- Senior Editor
|
0

Blue Bird Corp (NASDAQ:BLBD) Director Daniel Thau purchased 300 shares of common stock on May 19, 2026, according to an SEC filing. The transaction totaled $19,527.

The insider purchase follows a 58% stock return over the past year. Shares currently trade at a P/E ratio of 16.

Shares were bought at a weighted average price of $65.09, ranging from $65.05 to $65.11. After the purchase, Thau directly holds 8,696 shares.

According to Bond.az analysis, the stock appears undervalued. A comprehensive Pro Research Report is available for deeper insights.

In recent news, Blue Bird reported strong Q2 fiscal 2026 results. EPS reached $1.00, beating estimates of $0.87. Revenue hit $353 million, above the forecasted $336.63 million.

Needham raised its price target from $78 to $86, maintaining a Buy rating.

More News
Today / 16:20
|
834

Trio-Tech Director Sells $818,325 in Shares

Trio-Tech International director Jason Adelman sold 50,000 shares for $818,325. Stock surged 424% over the past year but appears overvalued.

0
Today / 15:34
|
459

AMPCO Pittsburgh CEO buys $29,791 in stock

AMPCO Pittsburgh CEO Brett McBrayer bought $29,791 in company stock. Shares dropped 20% last week but gained 201% over the past year.

0
Today / 15:24
|
946

Farmers & Merchants director sells $241,650 in stock

Farmers & Merchants Bancorp director Andrew J. Briggs sold $241,650 in stock. Dividend increase and other updates.

0
Today / 14:53
|
878

Fossil director buys $100,730 in shares

Fossil Group director Wendy Schoppert buys $100,730 in shares. The company also reported better-than-expected Q1 2026 financial results.

0
Today / 02:13
|
367

Artiva insider sells $63,072 in stock

Artiva Biotherapeutics insider Christopher Horan sells $63,072 in stock. Latest clinical updates and analyst rating included.

0
Today / 02:11
|
275

Artiva Biotherapeutics SVP Sells $27,879 in Stock

Artiva Biotherapeutics SVP Heather Raymon sells $27,879 in stock. Stock down 18.6% this week but up 296% over the year. Insights from Bond.az.

0
Today / 01:40
|
272

Fold Holdings director buys $10,551 in shares

Fold Holdings director buys $10,551 in shares as stock nears 52-week low. Financial results miss expectations.

0
Today / 01:40
|
785

Netlist CFO sells $23,311 in stock

Netlist CFO Gail Sasaki sells $23,311 worth of shares for tax obligations. Stock up 238% in year but down 24% in week.

0
Today / 01:31
|
364

MeiraGTx CEO Forbes Alexandria sells $568,540 in shares

MeiraGTx CEO Forbes Alexandria sells $568,540 in shares. The stock has returned 66% over the past year but faces profitability challenges.

0
Today / 01:30
|
868

Archer Aviation CFO Sells $73,896 in Stock

Archer Aviation Chief Accounting Officer Harsh Rungta sold $73,896 worth of stock. The sale was to cover tax withholding obligations.

0
Today / 01:22
|
374

Outset Medical GC sells $9,760 in shares

Outset Medical General Counsel John Brottem sold $9,760 worth of shares. The stock is down 80% over the past year.

0
Today / 01:21
|
331

FTV entities sell $159.45M in Neptune Insurance stock

FTV-affiliated funds sold over 6 million shares of Neptune Insurance Holdings for approximately $159.45 million. Analysts forecast profitability this year.

0
...